European Health Data Space – Opportunity for Innovation and Economic Growth – Vision or Reality?

November 15, 2022, Liechtenstein Palace, Prague

Watch the debate in English:

Concept

On 4 May 2022, the European Commission presented a proposal for a Regulation on the European Health Data Space (EHDS), which is the first sectoral adaptation of the European Data Space based on the so-called Data Governance Act.

The aim of the conference is to introduce and discuss the benefits of electronic health data sharing and use, especially for secondary purposes (R&D, regulatory and decision-making).

The conference will be an opportunity to share best practices from European countries and demonstrate the potential of a European market for digital health services and goods to support research, innovation, faster learning and deployment of artificial intelligence, and better and faster diagnosis and treatment of diseases. Synergies between the EHDS vision and the Member States experience, and aspiration will be explored to identify the key challenges to overcome to achieve the goal.

Organizers

The Czech Chamber of Commerce in collaboration with the Association of the Innovative Pharmaceutical Industry of the Czech Republic (AIFP).

Under the auspices of the Office of the Government.

Part of the events under the Czech Presidency of the EU Council.

Speakers Booklet

Speakers Presentations

Draft program

8:30-9:00 Registration of participants, welcome coffee

9:05-9:20 Opening speeches
Tomáš Prouza, Vice-President, Czech Chamber of Commerce
Jakub Dvořáček, Deputy Minister, Ministry of Health of the Czech Republic

9:20-9:40 What are the core stones of the European Health Data Space?
Joint Action towards EHDS = TEHDAS
Elina Drakvik, Specialist, Health Data 2030, Finnish Innovation Fund Sitra

9:40-10:00 European strategy for data – Data Governance Act – a vision of a European market for data
What are the opportunities for economic growth, research and innovation?
Petr Očko, Deputy Minister for Digitalization and Innovation, Ministry of Industry and Trade of the Czech Republic
Q&A

10:00-10:45 European Health Data Space – What is the vision, potential benefits and risks?
Introduction of the European Health Data Space Regulation
Fulvia Raffaelli, Head of Digital Health Unit, DG SANTÉ, European Commission
Reflection of the current status quo of negotiation in the EU Council and aspirations of the Czech Presidency
Zdeněk Gütter, Expert responsible for EHDS, Department of IT and Electronization of Healthcare, Ministry of Health of the Czech Republic
Q&A

10:45-11:00 Coffee Break

11:00-12:00 Use of health data for secondary purposes – best practice sharing – motivation for others (Part I)
Lisbeth Nielsen, Director General, Danish Health Data Authority
Ladislav Dušek, Director, Institute for Health Information and Statistics of the Czech Republic (ÚZIS)
Peter Rijnbeek, Chair of the Department of Medical Informatics of Erasmus MC, The Netherlands, Coordinator of the IMI2 EHDEN project
Q&A

12:00-12:15 Open data and its potential for R&D and innovations – vision and reality from the Czech perspective
Štěpán Jurajda, Deputy Minister for Science, Research and Innovation, Government of the Czech Republic
Marián Hajdúch, Member of the Research, Development and Innovation Council, Government of the Czech Republic

12:15-12:30 Using health data to drive innovation and competitiveness – the perspective of the Innovative Pharmaceutical Industry
Thomas Brookland, Digital Health WG Chair, European Federation of Pharmaceutical Industries and Associations

12:30-13:30 Lunch

13:30-13:45 European Health Data Space – the perspective of the European Parliament
Tomislav Sokol, Member of the European Parliament, Rapporteur in the Committee on the Environment, Public Health and Food Safety (ENVI)

13:45-14:45 Use of health data for secondary purposes – best practice sharing – motivation for others (Part II)
Anders Gustafsson, Vice-President, Karolinska Institutet, Sweden
Clara Hellner, Research and Innovation Director at Stockholm Region, Karolinska Institutet, Sweden
Hans Constandt, Project Manager, Belgium Health Data Authority
Dipak Kalra, President, European Institute for Innovation through Health Data
Q&A

14:45-16:30 High-level panel discussion – What do we expect from the EHDS? What is the point of view of different key stakeholders?
moderator: Daniel Dalton, ex-Member of the European Parliament (2015-2019), Head of the Advisory Board of the Allied for Start Ups
Ondřej Knotek, Member of the European Parliament
Fulvia Raffaelli, Head of Digital Health Unit, DG SANTÉ, European Commission
Lisbeth Nielsen, Director General, Danish Health Data Authority
Maria Backlund Hassel, Senior International Coordinator, Swedish eHealth Agency
Milan Macek, Head of the Institute of Biology and Medical Genetics, University Hospital Motol, Czech Republic, Coordinator, National Coordination Centre for Rare Diseases project
Thomas Brookland, Digital Health WG Chair, European Federation of Pharmaceutical Industries and Associations
Robert Hejzák, Chair, National Association of Patient Organizations of the Czech Republic

16:30-16:50 Final remarks and closing
Tomáš Prouza, Vice-President, Czech Chamber of Commerce
David Kolář, Executive Director, Czech Association of the Innovative Pharmaceutical Industry
16:50-18:00 Networking buffet after the conference

Networking buffet after the conference